| COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry L Garrigós, C Saura, C Martinez-Vila, A Zambelli, M Bower, B Pistilli, ... Therapeutic Advances in Medical Oncology 13, 17588359211053416, 2021 | 9 | 2021 |
| Gynaecological malignancies after breast cancer diagnosis: A population-based study MP Barretina-Ginesta, J Galceran, H Pla, C Meléndez, AC Bague, ... Clinical Journal of Obstetrics and Gynecology 2 (2), 113-118, 2019 | 3 | 2019 |
| Mortality of women with ductal carcinoma in situ of the breast: A population-based study from the Girona province, Spain (1994–2013) A Roca-Barceló, G Viñas, H Pla, A Carbó, R Comas, Á Izquierdo, ... Clinical and Translational Oncology 21, 891-899, 2019 | 2 | 2019 |
| Elderly patients with hormone receptor-positive HER2-negative metastatic breast cancer treated with CDK4/6 inhibitors in a multicentre cohort H Pla, E Felip, V Obadia, S Pernas, G Viñas, M Margelí, R Fort-Culillas, ... Clinical and Translational Oncology, 1-11, 2024 | 1 | 2024 |
| Prognostic Role of Neutrophil, Monocyte and Platelet to Lymphocyte Ratios in Advanced Ovarian Cancer According to the Time of Debulking Surgery A Plaja, I Teruel, M Ochoa-de-Olza, M Cucurull, ÁJ Arroyo, B Pardo, I Ortiz, ... International Journal of Molecular Sciences 24 (14), 11420, 2023 | 1 | 2023 |
| The prognostic impact of monocyte to lymphocyte ratio (MLR) in advanced epithelial ovarian cancer (EOC) MC Salamero, I ruel Te García, AJ Arroyo, B Pardo, M Gil, JM Piulats, ... Annals of Oncology 30, v417, 2019 | 1 | 2019 |
| Risk of endometrial cancer after RRSO in BRCA 1/2 carriers: a multicentre cohort study H Pla-Juher, M Pardo, ÀJ Izquierdo, E Darder, A Carbó, E Munté, ... Clinical and Translational Oncology 26 (4), 1033-1037, 2024 | | 2024 |
| Risk of endometrial cancer after RRSO in BRCA 1/2 carriers: a multicentre cohort study H Pla, M Pardo, A Izquierdo Font, E Darder Bernabeu, A CARBÓ, E Munté, ... Springer, 2024 | | 2024 |
| Nivolumab-Induced Autoimmune Haemolytic Anaemia and Safety of Subsequent Use of Ipilimumab: A Case Report A Carbó-Bagué, R Fort-Culillas, H Pla-Juher, J Rubió-Casadevall Case Reports in Oncology 14 (3), 1289-1294, 2022 | | 2022 |
| 268P Results from a real-world study of patients (pts) with hormone-receptor (HR)-positive HER2-negative metastatic breast cancer (MBC) treated with CDK4/6 inhibitors (CDK 4/6i … H Pla Annals of Oncology 33 (S660), 2022 | | 2022 |
| COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry L Garrigós Cubells, C Martinez-Vila, A Zambelli, M Bower, B Pistilli, H Pla, ... SAGE Publications, 2021 | | 2021 |
| 69P TGFBI promoter methylation validation as an epigenetic biomarker for trastuzumab resistance in HER2+ breast cancer patients cohort H Pla, Á Díaz-Lagares, A Hernandez, G Oliveras, F Pérez-Bueno, ... Annals of Oncology 31, S38, 2020 | | 2020 |
| Sweet Syndrome: a paraneoplasic syndrome related to ovarian cancer A Carbó-Bagué, R Liñan, H Pla-Juher, C Meléndez Frigola, L Cárdenas, ... Annals of Clinical Case Reports, 2019, vol. 4, art. núm. 1744, 2019 | | 2019 |
| Gynaecological malignancies after breast cancer diagnosis: A population-based study. R Marcos Gragera, MP Barretina, C Meléndez, H Pla, A Carbó, ... Clinical Journal of Obstetrics and Gynecology, 2019, 2019 | | 2019 |
| EP1. 12-15 Oncologic Treatments and Outcomes for Small-Cell Lung Cancer Patients with Brain Metastases J Bosch-Barrera, A Hernandez, N Priego, M Puigdemont, E Sais, N Quer, ... Journal of Thoracic Oncology 14 (10), S1021-S1022, 2019 | | 2019 |
| Mortality of women with ductal carcinoma in situ of the breast: a population‑based study from the Girona province, Spain A Roca‑Barceló, G Viñas, H Pla, A Carbó, R Comas, Á Izquierdo, ... | | 2018 |
